Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Debt / NOTE 3.250% 7/0
-
Number of holders
-
1
-
Total 13F principal, excl. options
-
10M
-
Principal change
-
+10M
-
Total reported value, excl. options
-
$10.3M
-
Value change
-
+$10.3M
-
Number of buys
-
1
-
Price
-
$1.03
Significant Holders of INTERCEPT PHARMACEUTICALS IN - NOTE 3.250% 7/0 as of Q2 2016
1 filing reported holding 45845PAA6 - INTERCEPT PHARMACEUTICALS IN - NOTE 3.250% 7/0 as of Q2 2016.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.